Four- and Five-Color Flow Cytometry Analysis of Leukocyte Differentiation Pathways in Normal Bone Marrow: A Reference Document Based on a Systematic Approach by the GTLLF and GEIL

被引:54
作者
Arnoulet, Christine [1 ]
Bene, Marie C. [2 ,3 ]
Durrieu, Francoise [4 ]
Feuillard, Jean [5 ]
Fossat, Chantal [6 ]
Husson, Bernard [7 ]
Jouault, Helene [8 ]
Maynadie, Marc [9 ]
Lacombe, Francis [10 ]
机构
[1] Inst J Paoli I Calmettes, Marseilles, France
[2] CHU Nancy Brabois, Nancy, France
[3] Nancy Univ, Nancy, France
[4] Inst Bergonie, Bordeaux, France
[5] CHU Dupuytren, Limoges, France
[6] CHU La Timone, Marseille, France
[7] Hop Jolimont, La Haine St Paul, Belgium
[8] CHU Henri Mondor, F-94010 Creteil, France
[9] CHU Bocage, Dijon, France
[10] CHU Haut Leveque, Bordeaux, France
关键词
bone marrow; flow cytometry; normal subjects; reference pattern of hematopoietic differentiation; ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; IMMUNOPHENOTYPIC ANALYSIS; MYELODYSPLASTIC SYNDROMES; PERIPHERAL-BLOOD; CELLS; PRECURSORS; CLASSIFICATION; POPULATIONS;
D O I
10.1002/cyto.b.20484
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Background: The development of multiparameter flow cytometry (FCM) and increasingly sophisticated analysis software has considerably improved the exploration of hematological disorders. These tools have been widely applied in leukaemias, lymphomas, and myelodysplasias, yet with very heterogeneous approaches. Consequently, there is no extensive reference document reporting on the characteristics of normal human bone marrow (BM) in multiparameter FCM. Here, we report a reference analysis procedure using relevant antibody combinations in normal human BM. Methods: A first panel of 23 antibodies, constructed after literature review, was tested in four-color combinations (including CD45 in each) on 30 samples of BM. After evaluation of the data, a second set of 22 antibodies was further applied to another 35 BM samples. All list-modes from the 65 bone marrow samples were reviewed collectively. A systematised protocol for data analysis was established including biparametric representations and color codes for the three major lineages and undifferentiated cells. Results: This strategy has allowed to obtain a reference atlas of relevant patterns of differentiation antigens expression in normal human BM that is available within the European LeukemiaNet. This manuscript describes how this atlas was constructed. Conclusions: Both the strategy and atlas could prove very useful as a reference of normality, for the determination of leukemia-associated immunophenotypic patterns, analysis of myelodysplasia and, ultimately, investigation of minimal residual disease in the BM. (C) 2009 Clinical Cytometry Society
引用
收藏
页码:3 / 10
页数:8
相关论文
共 32 条
[1]
Assessment of neutrophil activation in whole blood by flow cytometry [J].
Alvarez-Larrán, A ;
Toll, T ;
Rives, S ;
Estella, J .
CLINICAL AND LABORATORY HAEMATOLOGY, 2005, 27 (01) :41-46
[2]
BENE MC, 1995, LEUKEMIA, V9, P1783
[3]
Development of human lymphoid cells [J].
Blom, Blanca ;
Spits, Hergen .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :287-320
[4]
IMMUNOPHENOTYPING OF ACUTE-LEUKEMIA BY FLOW CYTOMETRIC ANALYSIS - USE OF CD45 AND RIGHT-ANGLE LIGHT SCATTER TO GATE ON LEUKEMIC BLASTS IN 3-COLOR ANALYSIS [J].
BOROWITZ, MJ ;
GUENTHER, KL ;
SHULTS, KE ;
STELZER, GT .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (05) :534-540
[5]
Braylan RC, 2001, CYTOMETRY, V46, P23, DOI 10.1002/1097-0320(20010215)46:1<23::AID-CYTO1033>3.0.CO
[6]
2-Z
[7]
Minimal residual disease studies by flow cytometry in acute leukemia [J].
Campana, D ;
Coustan-Smith, E .
ACTA HAEMATOLOGICA, 2004, 112 (1-2) :8-15
[8]
Ciudad J, 1998, HAEMATOLOGICA, V83, P1069
[9]
CELL-SURFACE ANTIGENS ON HUMAN MARROW-CELLS - DISSECTION OF HEMATOPOIETIC DEVELOPMENT USING MONOCLONAL-ANTIBODIES AND MULTIPARAMETER FLOW-CYTOMETRY [J].
CIVIN, CI ;
LOKEN, MR .
INTERNATIONAL JOURNAL OF CELL CLONING, 1987, 5 (04) :267-288
[10]
Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia [J].
Coustan-Smith, E ;
Sancho, J ;
Hancock, ML ;
Razzouk, BI ;
Ribeiro, RC ;
Rivera, GK ;
Rubnitz, JE ;
Sandlund, JT ;
Pui, CH ;
Campana, D .
BLOOD, 2002, 100 (07) :2399-2402